MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202411088715 A) filed by Translational Health Science And Technology on November 16, 2024, for Bis(benzylisoquinoline) Alkaloids As Tlr4 Agonist.
Inventors include Awasthi, Amit; Sadhu, Srikanth; Dalal, Rajdeep; Salunke, Deepak B.; and Batra, Aashima.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: The present invention discloses bis(benzylisoquinoline) alkaloid compounds, their synthesis, a combination and composition for activity against TLR4 receptors. The compounds of the present invention also show synergistic effect with other antibiotics.
Disclaimer: Curated by HT Syndication.
